2026 data ClinicalTrials.gov official source

Conditions: I

Every condition beginning with I that has a registered US clinical trial, with how many studies cover each.

PlainTrial home → About this data

1,106 conditions starting with "I"

Showing 951–1,000 of 1,106

Sort by: Name Most Trials Recruiting
Condition Trials
Invasive Adenocarcinoma of the Breast 1
Invasive Aspergillosis 2
Invasive Bladder Cancer 1
Invasive Bladder Giant Cell Urothelial Carcinoma 1
Invasive Bladder Lymphoepithelioma-Like Carcinoma 1
Invasive Bladder Plasmacytoid Urothelial Carcinoma 1
Invasive Bladder Sarcomatoid Urothelial Carcinoma 1
Invasive Breast Cancer 20
Invasive Breast Carcinoma 46
Invasive Breast Carcinoma of No Special Type 1
Invasive Breast Lobular Carcinoma 1
Invasive Cancer 1
Invasive Candidiasis 6
Invasive Carcinoma 1
Invasive Carcinoma of Breast 1
Invasive Carcinoma of the Breast 1
Invasive Cervical Cancer 1
Invasive Duct Carcinoma of Breast 1
Invasive Ductal and Invasive Lobular Breast Carcinoma 1
Invasive Ductal Breast Carcinoma 5
Invasive Ductal Breast Carcinoma Stage IV 1
Invasive Ductal Breast Carcinoma With Predominant Intraductal Component 1
Invasive Ductal Carcinoma 2
Invasive Ductal Carcinoma of Female Breast 1
Invasive Ductal Carcinoma, Breast 1
Invasive Epithelial Ovarian Cancer 1
Invasive Fungal Disease 2
Invasive Fungal Infection 1
Invasive Fungal Infections 5
Invasive Lobular Breast Carcinoma 3
Invasive Lobular Breast Carcinoma With Predominant in Situ Component 1
Invasive Lobular Carcinoma 1
Invasive Malignancy (Any Type) 1
Invasive Mammary Carcinoma 1
Invasive Mechanical Ventilation 1
Invasive Meningococcal Disease 1
Invasive Mold Infections 1
Invasive Pulmonary Aspergillosis 2
Invasive Pulmonary Fungal Infection 1
Invasive Pulmonary Zygomycosis 1
Invasive Sarcomatoid Urothelial Carcinoma 1
Involutional Depression 2
iO Resistant sqNSCLC 1
IOL 1
IOP 1
IPEX 1
IPF 4
IPMN 1
IPMN, Pancreatic 2
IPV 1

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details.